Skip to main content
Top
Published in: AIDS Research and Therapy 1/2024

Open Access 01-12-2024 | Secondary Syphilis | Case Report

Secondary syphilis presenting with alopecia and leukoderma in a stable HIV-positive patient in a resource-limited setting: a case report

Authors: Sukoluhle Khumalo, Yves Mafulu, Victor Williams, Normusa Musarapasi, Samson Haumba, Nkululeko Dube

Published in: AIDS Research and Therapy | Issue 1/2024

Login to get access

Abstract

Background

Syphilis is an infection caused by the bacteria Treponema pallidum. It is mainly transmitted through oral, vaginal and anal sex, in pregnancy and through blood transfusion. Syphilis develops in primary, secondary, latent and tertiary stages and presents with different clinical features at each stage. Infected patients can remain asymptomatic for several years and, without treatment, can, in extreme cases, manifest as damage in several organs and tissues, including the brain, nervous tissue, eyes, ear and soft tissues. In countries with a high human immunodeficiency virus (HIV) burden, syphilis increases the risk of HIV infections. We report the case of a young HIV-positive black woman who presented with alopecia and hypopigmentation as features of secondary syphilis.

Case presentation

A virologically suppressed 29-year-old woman on Anti-retroviral Therapy (ART) presented with a short history of generalized hair loss associated with a non-itchy maculopapular rash and skin depigmentation on the feet. Limited laboratory testing confirmed a diagnosis of secondary syphilis. She was treated with Benzathine Penicillin 2.4MU. After receiving three doses of the recommended treatment, the presenting features cleared, and the patient recovered fully.

Conclusion

This case demonstrates the importance of a high index of clinical suspicion and testing for syphilis in patients presenting with atypical clinical features of secondary syphilis, such as hair loss and hypopigmentation. It also highlights the challenges in diagnosing and clinically managing syphilis in a resource-limited setting.
Literature
3.
go back to reference Ginindza TG, Stefan CD, Tsoka-Gwegweni JM, Dlamini X, Jolly PE, Weiderpass E, et al. Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infect Agent Cancer. 2017;12:29.CrossRefPubMedPubMedCentral Ginindza TG, Stefan CD, Tsoka-Gwegweni JM, Dlamini X, Jolly PE, Weiderpass E, et al. Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infect Agent Cancer. 2017;12:29.CrossRefPubMedPubMedCentral
4.
go back to reference Peeling RW, Hook EW. The pathogenesis of syphilis: the great mimicker, revisited. J Pathol. 2006;208(2):224–32.CrossRefPubMed Peeling RW, Hook EW. The pathogenesis of syphilis: the great mimicker, revisited. J Pathol. 2006;208(2):224–32.CrossRefPubMed
6.
go back to reference Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013;24(5):351–5.CrossRefPubMedPubMedCentral Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013;24(5):351–5.CrossRefPubMedPubMedCentral
7.
go back to reference Carlson JA, Dabiri G, Cribier B, Sell S. The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity. Am J Dermatopathol. 2011;33(5):433–60.CrossRefPubMedPubMedCentral Carlson JA, Dabiri G, Cribier B, Sell S. The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity. Am J Dermatopathol. 2011;33(5):433–60.CrossRefPubMedPubMedCentral
9.
11.
go back to reference Amrani A, Sil A, Das A. Cutaneous signs in infectious diseases. Indian J Dermatol Venereol Leprol. 2022;88(4):569–75.CrossRefPubMed Amrani A, Sil A, Das A. Cutaneous signs in infectious diseases. Indian J Dermatol Venereol Leprol. 2022;88(4):569–75.CrossRefPubMed
13.
go back to reference Jordaan HF, Louw M. The moth-eaten alopecia of secondary syphilis. A histopathological study of 12 patients. Am J Dermatopathol. 1995;17(2):158–62.CrossRefPubMed Jordaan HF, Louw M. The moth-eaten alopecia of secondary syphilis. A histopathological study of 12 patients. Am J Dermatopathol. 1995;17(2):158–62.CrossRefPubMed
14.
go back to reference Cuozzo DW, Benson PM, Sperling LC, Skelton HG. Essential syphilitic alopecia revisited. J Am Acad Dermatol. 1995;32(5 Pt 2):840–3.CrossRefPubMed Cuozzo DW, Benson PM, Sperling LC, Skelton HG. Essential syphilitic alopecia revisited. J Am Acad Dermatol. 1995;32(5 Pt 2):840–3.CrossRefPubMed
15.
go back to reference Lee JYY, Hsu ML. Alopecia Syphilitica, a simulator of Alopecia Areata: histopathology and differential diagnosis. J Cutan Pathol. 1991;18(2):87–92.CrossRefPubMed Lee JYY, Hsu ML. Alopecia Syphilitica, a simulator of Alopecia Areata: histopathology and differential diagnosis. J Cutan Pathol. 1991;18(2):87–92.CrossRefPubMed
16.
go back to reference Eyer-Silva W, de Martins A, Silva CJ, Acakpovi GAR. G, Pinto JF da C. Secondary syphilis presenting as leucoderma syphiliticum: case report and review. Rev Inst Med Trop Sao Paulo. 2017;59:e74. Eyer-Silva W, de Martins A, Silva CJ, Acakpovi GAR. G, Pinto JF da C. Secondary syphilis presenting as leucoderma syphiliticum: case report and review. Rev Inst Med Trop Sao Paulo. 2017;59:e74.
17.
go back to reference de Miranda MFR, Bittencourt M, de JS, Lopes I, da Cumino C. S do SM. Leucoderma syphiliticum: a rare expression of the secondary stage diagnosed by histopathology. An Bras Dermatol. 2010;85:512–5. de Miranda MFR, Bittencourt M, de JS, Lopes I, da Cumino C. S do SM. Leucoderma syphiliticum: a rare expression of the secondary stage diagnosed by histopathology. An Bras Dermatol. 2010;85:512–5.
19.
go back to reference Sil A, Bhanja DB, Panigrahi A, Biswas SK. Acquired Epidermodysplasia Verruciformis during highly active antiretroviral therapy. Indian J Dermatol. 2022;67(3):316.CrossRefPubMedPubMedCentral Sil A, Bhanja DB, Panigrahi A, Biswas SK. Acquired Epidermodysplasia Verruciformis during highly active antiretroviral therapy. Indian J Dermatol. 2022;67(3):316.CrossRefPubMedPubMedCentral
20.
go back to reference Rao M, Young K, Jackson-Cowan L, Kourosh A, Theodosakis N. Post-inflammatory Hypopigmentation: review of the etiology, clinical manifestations, and Treatment options. J Clin Med. 2023;12(3):1243.CrossRefPubMedPubMedCentral Rao M, Young K, Jackson-Cowan L, Kourosh A, Theodosakis N. Post-inflammatory Hypopigmentation: review of the etiology, clinical manifestations, and Treatment options. J Clin Med. 2023;12(3):1243.CrossRefPubMedPubMedCentral
21.
go back to reference Ciupińska M, Skibińska J, Sikora M, Blicharz L, Kotowska M, Rudnicka L. Nonscarring Alopecia and Hypopigmented lesions May be unusual signs of secondary Syphilis. Skin Appendage Disord. 2021;7(3):203–5.CrossRefPubMedPubMedCentral Ciupińska M, Skibińska J, Sikora M, Blicharz L, Kotowska M, Rudnicka L. Nonscarring Alopecia and Hypopigmented lesions May be unusual signs of secondary Syphilis. Skin Appendage Disord. 2021;7(3):203–5.CrossRefPubMedPubMedCentral
22.
go back to reference Hernández-Bel P, Unamuno B, Sánchez-Carazo JL, Febrer I, Alegre V. Syphilitic alopecia: a report of 5 cases and a review of the literature. Actas Dermosifiliogr. 2013;104(6):512–7.CrossRefPubMed Hernández-Bel P, Unamuno B, Sánchez-Carazo JL, Febrer I, Alegre V. Syphilitic alopecia: a report of 5 cases and a review of the literature. Actas Dermosifiliogr. 2013;104(6):512–7.CrossRefPubMed
Metadata
Title
Secondary syphilis presenting with alopecia and leukoderma in a stable HIV-positive patient in a resource-limited setting: a case report
Authors
Sukoluhle Khumalo
Yves Mafulu
Victor Williams
Normusa Musarapasi
Samson Haumba
Nkululeko Dube
Publication date
01-12-2024
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2024
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-024-00603-w

Other articles of this Issue 1/2024

AIDS Research and Therapy 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine